PHARMACOLOGICAL THERAPY FOR STABLE COPD

Bronchodilators

_{^{are medications that increase FEV1 and/or change other spirometric variables}}

Bronchodilator medications in COPD are most often given on a regular basis to prevent or reduce symptoms

Toxicity is also dose-related

Use of short acting bronchodilators on a regular basis is not generally recommended

COMBINATION BRONCHODILATOR THERAPY

Combining bronchodilators with different mechanisms and durations of action may increase the degree of bronchodilation with a lower risk of side effects compared to increasing the dose of a single bronchodilator

sd

sd

sd

ds